Streetbeat News

Products Services

AEMD

CMRX

GOVX

INO

MRNA

SIGA

TNXP

The World Health Organization (WHO) has begun a press conference to discuss the potential declaration of an emergency regarding the Mpox virus. This could have significant implications for companies involved in the development of vaccines and treatments for the virus.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 5:25 pm

D

EQNR

The U.S. Interior Department announced that Equinor and Dominion Energy have won offshore wind leases in the Central Atlantic. Equinor's winning bid was $75 million, while Dominion's bid was $17.7 million.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 5:12 pm

XXII

22nd Century Group has received a Notice of Allowance for its U.S. Patent Application 17/785,153 titled 'GENETIC APPROACH FOR ACHIEVING ULTRA LOW NICOTINE CONTENT IN TOBACCO'.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 5:07 pm

GILD

The FDA has approved Gilead Sciences' new drug, Livdelzi, for the treatment of Primary Biliary Cholangitis, according to Reuters citing the company's website.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 5:03 pm

RIOT

Riot Platforms, Inc. (NASDAQ:RIOT) announced the acquisition of one million common shares of Bitfarms, increasing its ownership to 18.90%. Additionally, Riot reported a significant increase in Bitcoin production and hash rate for July 2024, and announced the acquisition of Block Mining, which will boost its self-mining capacity. Despite these positive developments, Riot's stock is down 2.68% to $7.63.

Portfolio Pulse from Dylan Berman

August 14, 2024 | 5:03 pm

MRAM

Everspin Technologies has been awarded a contract worth up to $9.25 million to provide its MRAM technology for the development of radiation-hardened eMRAM macro for Frontgrade Technologies. This contract supports the Department of Defense's aerospace and defense electronics production.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 5:02 pm

ABBV

Deep-pocketed investors are showing a bullish sentiment towards AbbVie (NYSE:ABBV) with significant options activity. Benzinga's options scanner highlighted 9 extraordinary options activities, with a majority being calls. Analysts have set an average price target of $209.4, with ratings ranging from Overweight to Buy.

Portfolio Pulse from Benzinga Insights

August 14, 2024 | 5:00 pm

TME

BofA Securities analyst Lei Zhang reiterated a Buy rating on Tencent Music Entertainment Group (NYSE:TME) with a price target of $15, down from $18. Despite missing revenue estimates for Q2 2024, the company met EPS expectations. Zhang highlighted the company's focus on ARPU growth and premium services, which could drive profitability. The price target cut reflects a lowered average fiscal 2025 P/E of 20x amid a weak market.

Portfolio Pulse from Anusuya Lahiri

August 14, 2024 | 4:56 pm

ALB

LAC

LIT

SQM

Shares of lithium companies are trading lower amid a drop in the price of the metal.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 4:45 pm

APP

Investors with significant capital are showing a bullish stance on AppLovin (NASDAQ:APP), as evidenced by recent options trading activity. Benzinga's options scanner detected 29 trades, with 62% being bullish. The price range targeted by these trades is between $60.0 and $125.0. The stock is currently up 5.5% at $84.18, with RSI indicators suggesting it may be overbought. Analysts have issued ratings with a consensus target price of $98.33.

Portfolio Pulse from Benzinga Insights

August 14, 2024 | 4:30 pm